GBP1 and colorectal neoplasm: To test whether this mechanism holds true at the tissue-level, we used IFNγ-responsive, patient-derived colorectal tumor organoids and tested if the GBP1:PIM1 interaction inhibitor NSC756093 affected cell viability, organoid growth and stemness.